[1] Feller L, Lemmer J. Oral Squamous Cell Carcinoma: Epidemiology, Clinical Presentation and Treatment. J Cancer Ther, 2012; 3, 263−8. doi:  10.4236/jct.2012.34037
[2] Leung KW and Wong AS. Pharmacology of ginsenosides: a literature review. Chin Med, 2010; 5, 20. doi:  10.1186/1749-8546-5-20
[3] Kim JH, Yi YS, Kim MY, et al. Role of ginsenosides, the main active components of Panax ginseng, in inflammatory responses and diseases. J Ginseng Res, 2017; 41, 435−43. doi:  10.1016/j.jgr.2016.08.004
[4] Ham YM, Lim JH, Na HK, et al. Ginsenoside-Rh2-induced mitochondrial depolarization and apoptosis are associated with reactive oxygen species- and Ca2+- mediated c-Jun NH2-terminal kinase 1 activation in HeLa cells. J Pharmacol Exp Ther, 2006; 319, 1276−85. doi:  10.1124/jpet.106.109926
[5] Shia CS, Suresh G, Hou YC, et al. Suppression on metastasis by rhubarb through modulation on MMP-2 and uPA in human A549 lung adenocarcinoma: an ex vivo approach. J Ethnopharmacol, 2011; 133, 426−33. doi:  10.1016/j.jep.2010.10.020
[6] Tang X P, Tang G D, Fang C Y, et al. Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells. World Journal of Gastroenterology, 2013; 19, 1582−92. doi:  10.3748/wjg.v19.i10.1582
[7] Rivera LB and Bergers G. Tumor angiogenesis, from foe to friend. Science, 2015; 349, 694−5. doi:  10.1126/science.aad0862
[8] Costache MI, Ioana M, Iordache S, et al. VEGF Expression in Pancreatic Cancer and Other Malignancies: A Review of the Literature. Rom J Intern Med, 2015; 53, 199−208.
[9] Ge G, Yan Y and Cai H. Ginsenoside Rh2 Inhibited Proliferation by Inducing ROS Mediated ER Stress Dependent Apoptosis in Lung Cancer Cells. Biol Pharm Bull, 2017; 40, 2117−24. doi:  10.1248/bpb.b17-00463
[10] Kim YM, Kim SJ, Tatsunami R, et al. ROS-induced ROS release orchestrated by Nox4, Nox2, and mitochondria in VEGF signaling and angiogenesis. Am J Physiol Cell Physiol, 2017; 312, 749−64. doi:  10.1152/ajpcell.00346.2016